Meta-analysis of 6 non-randomised studies in adults with cancer receiving paclitaxel: adding H2 antagonists to premedication did not significantly change grade III or higher hypersensitivity reactions (RR 1.04) or all-grade reactions (RR 1.40).
Meta-analysisn = 6 studies
AlZahrani et al. H2-antagonists in paclitaxel premedication: systematic review and meta-analysis